ARTICLE | Clinical News
Microplasmin: Final Phase IIa data
July 26, 2010 7:00 AM UTC
Final data from the double-blind, European Phase IIa MIVI-IIT trial in 60 patients showed that single intravitreal injections of 75, 125 or 175 µg microplasmin led to nonsurgical resolution of VMA in ...